Waters Quick Ratio (WAT) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Waters Corporation  (NYSE: WAT)

Waters's Quick Ratio

WAT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Waters's Cash & cash equivalent grew by 10.02 % in the Q3 2026 sequentially, while Current Liabilities decreased, this led to improvement in Waters's Quick Ratio to 0.27, Quick Ratio remained below Waters Corporation average.

Within Laboratory Analytical Instruments industry 18 other companies have achieved higher Quick Ratio than Waters in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 3058 to 3305.

Explain Quick Ratio?
How much Cash & cash equivalents WAT´s has?
What are WAT´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/WAT/financial-strength
https://api.csimarket.com/api/v1/companies/WAT/fundamentals
https://api.csimarket.com/api/v1/companies/WAT/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
WAT Quick Ratio (Oct 03 2026)
Q3
(Jul 04 2026)
Q2
(Apr 04 2026)
Q1
(Dec 31 2025)
Q4
(Sep 27 2025)
Q3
Y / Y Current Liabilities Change 84.28 %
Y / Y Cash & cash equivalent Change 29.16 %
Quick Ratio MRQ 0.27
WAT's Total Ranking # 3305
Seq. Current Liabilities Change -9.13 %
Seq. Cash & cash equivalent Change 10.02 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 19
Healthcare Sector # 815
Overall Market # 3305


Quick Ratio Statistics
High Average Low
8.03 2.49 0.2
(Mar 30 2019)   (Apr 04 2026)




Financial Statements
Waters's Current Liabilities $ 2,180 Millions Visit WAT's Balance sheet
Waters's Cash & cash equivalent $ 593 Millions Visit WAT's Balance sheet
Source of WAT's Sales Visit WAT's Sales by Geography


Cumulative Waters's Quick Ratio

WAT's Quick Ratio for the trailling 12 Months

WAT Quick Ratio

(Oct 03 2026)
12 Months
(Jul 04 2026)
12 Months
(Apr 04 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 27 2025)
12 Months
Y / Y Current Liabilities TTM Growth 109.76 %
Y / Y Cash & cash equivalent TTM Growth 42.18 %
Quick Ratio TTM 0.27
Total Ranking TTM # 4083
Seq. Current Liabilities TTM Growth 14.05 %
Seq. Cash & cash equivalent TTM Growth 6.54 %


  News about Waters Corporation Quick Ratio

Waters Corp Faces Challenges as Share Performance Falters Amidst Market Trends

This week, Waters Corp has seen its shares underperforming in comparison to the overall market, experiencing a decline in performance. Additionally, Waters Corp customers have witnessed a slight decrease in share value throughout the year. While the company s suppliers have faced deteriorating revenues, the sales have shown sequential growth. This article explores these developments and highlights the factors contributing to Waters Corp s current market challenges.Waters Corp Share PerformanceSo far this year, Waters Corp s share performance has fallen behind the market, registering a decrease of -0.91%. Despite the overall decrease, the company s customers have experienced a slight decline in share value during the same period. This suggests that Waters Corp is facing specific internal challenges that have impacted customer confidence.


On the trailing twelve months basis Due to decrease in Current Liabilities in the Q3 2026 to $2,180.00 millions, cumulative Quick Ratio decreased to 0.27 below the average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 22 other companies have achieved higher Quick Ratio than Waters. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 3217 to 4083.

Explain Quick Ratio?
How much Cash & cash equivalents WAT´s has?
What are WAT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 23
Healthcare Sector # 909
Within the Market # 4083


trailing twelve months Quick Ratio Statistics
High Average Low
1.72 0.81 0.29
(Mar 31 2019)   (Jul 04 2026)




Companies with similar Quick Ratio in the quarter ending Oct 03 2026, within Laboratory Analytical Instruments Industry Quick RatioOct 03 2026 MRQ Cash & cash equivalentOct 03 2026 MRQ Current Liabilities
Bionano Genomics Inc   0.66 $ 8.168  Millions$ 12.307  Millions
Revvity Inc  0.63 $ 592.799  Millions$ 936.977  Millions
Avantor Inc   0.34 $ 464.300  Millions$ 1,369.000  Millions
Waters Corporation  0.27 $ 593.000  Millions$ 2,180.000  Millions
Harvard Bioscience Inc   0.19 $ 4.856  Millions$ 26.127  Millions
Bruker Corporation  0.13 $ 148.100  Millions$ 1,172.100  Millions
BIOFORCE NANOSCIENCES HOLDINGS, INC.  0.11 $ 0.032  Millions$ 0.277  Millions

Date modified: 2026-11-12T05:50:52+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.